跳至主要内容
临床试验/IRCT20240213060992N1
IRCT20240213060992N1尚未招募4 期

Comparing the effect of low dose and standard dose Cyproheptadine on BMI enhancement in children aged 2-10 and evaluation of its side effects

Shahre-kord University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 years 至 10 years(—)
性别
All

入选标准

  • Consent of the child's guardian to participate in the study
  • Being aware and vigilant of the guardian of the child
  • Age 2 to 9 years and 6 months at the first visit
  • BMI Z-score is less than -2 standard deviations in the BMI table according to age and sex of the CDC, which is set based on 15day intervals.

排除标准

  • Celiac disease, Crohn's disease, sensitivity to cow's protein, hypothyroidism, hyperthyroidism, congenital megacolon, eosinophilic gastroenteritis, cystic fibrosis and any disease that causes malabsorption.
  • Allergy to antihistamines
  • Consumption of other appetite stimulants and multivitamins and zinc in the study
  • Treatment with growth hormone, gonadotropin-releasing hormone analog, aromatase inhibitors, recombinant human-like growth factor and androgen in the study
  • Entering stage 1 of puberty including the enlargement of testicles in boys, growth of pubic hair in boys, breast enlargement in girls

研究者

发起方
Shahre-kord University of Medical Sciences

相似试验